ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 78 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $95,000 | -61.7% | 100,000 | -51.7% | 0.01% | -61.1% |
| Q2 2022 | $248,000 | +89.3% | 206,856 | +106.9% | 0.02% | +157.1% |
| Q1 2022 | $131,000 | -25.6% | 100,000 | 0.0% | 0.01% | +16.7% |
| Q4 2021 | $176,000 | -59.4% | 100,000 | -50.0% | 0.01% | -64.7% |
| Q3 2021 | $434,000 | -89.8% | 200,000 | -44.3% | 0.02% | -95.6% |
| Q2 2019 | $4,268,000 | +124.7% | 358,986 | -0.9% | 0.39% | +125.6% |
| Q1 2019 | $1,899,000 | +66.3% | 362,386 | 0.0% | 0.17% | +149.3% |
| Q4 2018 | $1,142,000 | +560.1% | 362,386 | +1169.6% | 0.07% | +527.3% |
| Q3 2018 | $173,000 | -91.0% | 28,544 | -94.8% | 0.01% | -93.2% |
| Q4 2017 | $1,925,000 | -4.1% | 550,000 | 0.0% | 0.16% | -23.2% |
| Q3 2017 | $2,008,000 | +88.9% | 550,000 | +29.4% | 0.21% | +34.4% |
| Q2 2017 | $1,063,000 | +12.5% | 425,000 | +21.4% | 0.16% | +6.8% |
| Q1 2017 | $945,000 | +30.3% | 350,000 | +40.0% | 0.15% | +182.7% |
| Q4 2016 | $725,000 | – | 250,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |